TRUMF - Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q2 2022 Results - Earnings Call Transcript

Terumo Corporation (TRUMF) Q2 2022 Earnings Conference Call November 4, 2021 04:00 ET Company Participants Naoki Muto - Chief Accounting & Financial Officer Shinjiro Sato - President & Chief Executive Officer Conference Call Participants Presentation Naoki Muto I am the CAFO, Muto. I will now explain the Second Quarter Results for the fiscal year ending March 2022. First, the highlights from the quarter. Sales and profit were both our highest ever. In sales revenue, demand for Cardiac and Vascular Company products made a significant recovery from COVID-19 impact. Although that company was somewhat affected by a repeated wave of COVID due to the Delta variant, the other two companies covered that impact. In adjusted operating profit, a recovery in sales and product mix improvement both contributed. Expenses including SG&A which rose slowly in the first quarter, progressed as planned in the second quarter. There is no change in the guidance

For further details see:

Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q2 2022 Results - Earnings Call Transcript